Pain Relief in Patients With Chronic Low Back Pain Using HeatTens vs. Standard Care.
CompletedNot applicableNCT03643731
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
A two-armed randomized controlled clinical trial with blind assessments and a follow-up period of 4 weeks is developed. The aim of this study is to investigate the effects of the combination of heat and TENS (HeatTENS device) on pain in people with chronic low back pain. A sample of 70 patients will be recruited. Following baseline measurements, subjects will be randomly allocated to the experimental or the control group. The experimental group will be asked to use the device on a daily basis, 30 minutes per day. The control group will have no device. After 4 weeks of FU, measurements will be repeated.
Study details
- Official title
- Pain Relief in Patients With Chronic Low Back Pain Using HeatTens vs. Standard Care.
- Conditions
- Chronic Low Back Pain
- Movement Evoked Pain
- Interventions
- Device: HeatTens (HV-F311-E)
- Sponsor
- Vrije Universiteit Brussel
- Collaborators
- Omron Healthcare Co., Ltd.
- Start date
- 2018-08-29
- Primary completion
- 2019-08-09
- Sex
- All
- Age range
- from 25 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- Belgium
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * chronic nonspecific LBP for at least 3 months' duration: non-specific LBP implies that patients are not allowed to have any evidence of specific spinal pathology (e.g., hernia, spinal stenosis, spondylolisthesis, infection, spinal fracture or malignancy). Exclusion Criteria: * spinal surgery in the past 6 months * severe underlying comorbidity (like diagnosed diabetes, cardiovascular problems, etc.), * pregnant or given birth in the preceding year, * having initiated a new LBP treatment in the 6 weeks prior to study participation
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03643731